Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Xianhua Mao, Lung Yi Mak, Wai-Kay Seto

Clin Mol Hepatol. 2023;29(3):690-692. Published online May 30, 2023

DOI: https://doi.org/10.3350/cmh.2023.0173

View: 908 Download: 62

Philipp Kasper, Münevver Demir, Hans-Michael Steffen

Clin Mol Hepatol. 2023;29(2):390-393. Published online March 20, 2023

DOI: https://doi.org/10.3350/cmh.2023.0059

View: 1424 Download: 40 Citation: 1

San-Chi Chen

Clin Mol Hepatol. 2023;29(2):352-354. Published online March 20, 2023

DOI: https://doi.org/10.3350/cmh.2023.0101

View: 1442 Download: 48

Ju Dong Yang

Clin Mol Hepatol. 2019;25(4):335-343. Published online March 29, 2019

DOI: https://doi.org/10.3350/cmh.2019.0010

View: 9692 Download: 226 Citations: 34

Chung-Feng Huang, Ming-Lung Yu

Clin Mol Hepatol. 2019;25(2):168-171. Published online February 11, 2019

DOI: https://doi.org/10.3350/cmh.2018.1014

View: 5322 Download: 179 Citations: 4

Doo Yul Ryu,Duc Ky Lee,Jong Hyung Kim,Hyun Min Shin,Dong In Hwang,Dong Joo Lee,Sang Kook Han,Seok En Kim,Suk Joon Park

Clin Mol Hepatol. 1999;5(4):343-347. Published online January 1, 2000

View: 2047 Download: 13

Hyun Ju Park, Joung Il Lee, Seok Ho Dong, Hyo Jong Kim, Byoung Ho Kim, Young Woon Chang and Rin Chang

Clin Mol Hepatol. 1998;4(4):346-357. Published online January 1, 2000

View: 2156 Download: 14

1 |

Viewed By 7237	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 6230	A decade of liver organoids: Advances in disease modeling
Viewed By 4056	Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy
Viewed By 3441	MAFLD: How is it different from NAFLD?
Viewed By 3071	Hepatorenal syndrome: Current concepts and future perspectives

Cited By 117	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 54	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 52	From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Cited By 46	Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Cited By 46	Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis

Search